Table 4.
Differences of Hepatic Function Parameters during Follow-up Periods after Plug-Assisted Retrograde Transvenous Obliteration (n=54)
| Variable | Baseline | 1 Month after | p-value | 6 Months after | p-value | Mean follow-up | p-value |
|---|---|---|---|---|---|---|---|
| Serum creatinine, mg/dL | 0.98±0.30 | 0.97±0.26 | 0.700 | 0.99±0.22 | 0.804 | 1.05±0.30 | 0.059 |
| Albumin, mg/L | 3.39±0.65 | 3.74±0.58 | <0.001* | 3.73±0.68 | <0.001* | 3.58±0.73 | 0.056 |
| PT/INR | 1.26±0.22 | 1.21±0.17 | 0.002* | 1.22±0.20 | 0.017* | 1.22±0.21 | 0.213 |
| Total bilirubin, mg/dL | 1.49±1.25 | 1.26±0.86 | 0.039* | 1.47±0.94 | 0.768 | 1.70±1.36 | 0.304 |
| Child-Pugh score | 6.94±1.76 | 6.13±1.48 | <0.001* | 6.30±1.44 | <0.001* | 6.87±1.84 | 0.781 |
| MELD score | 11.46±4.35 | 10.06±2.95 | 0.006* | 10.33±2.96 | 0.021* | 11.09±3.41 | 0.457 |
Data are presented as mean±SD. Note: mean follow-up duration, 28.0±19.8 months (range, 6–78 months).
PT/INR, prothrombin time/international normalized ratio; MELD, Model for End-Stage Liver Disease.
*Statistically significant, p<0.05.